Open AccessIntegrin antagonists are effective and safe for Crohn’s disease: A meta-analysis
Author(s) -
Wensong Ge,
JianGao Fan
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i15.4744
Subject(s) - vedolizumab , medicine , natalizumab , meta analysis , cochrane library , adverse effect , placebo , crohn's disease , gastroenterology , medline , disease , pathology , alternative medicine , political science , law
To evaluate the efficacy and safety of integrin antagonists, including natalizumab and vedolizumab, in Crohn's disease (CD).